All Bundibugyo virus disease articles
-
NewsUganda launches Phase I clinical study of Bundibugyo virus disease vaccine
A Phase I clinical study has been launched evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV). The study is part of an international effort to develop vaccines against Ebola virus species for which no licensed vaccines are currently available.
-
NewsKenya confirms first imported Bundibugyo virus disease case; WHO supports control efforts
Following the confirmation by Kenyan authorities of the country’s first imported case of Bundibugyo virus disease (BVD), the World Health Organization (WHO) is working closely with the Government of Kenya to intensify key control measures to prevent further spread of the virus.